Glucose Health Current Ratio 2014-2019 | GLUC
Glucose Health current ratio from 2014 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Glucose Health Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2019-09-30 | $0.00B | $0.00B | 0.60 |
| 2019-06-30 | $0.00B | $0.00B | 0.86 |
| 2019-03-31 | $0.00B | $0.00B | 0.24 |
| 2018-12-31 | $0.00B | $0.00B | 0.16 |
| 2018-09-30 | $0.00B | $0.00B | 0.31 |
| 2018-06-30 | $0.00B | $0.00B | 0.27 |
| 2018-03-31 | $0.00B | $0.00B | 0.18 |
| 2017-12-31 | $0.00B | $0.00B | 0.06 |
| 2017-09-30 | $0.00B | $0.00B | 0.06 |
| 2017-06-30 | $0.00B | $0.00B | 0.06 |
| 2017-03-31 | $0.00B | $0.00B | 0.03 |
| 2016-12-31 | $0.00B | $0.00B | 0.06 |
| 2016-09-30 | $0.00B | $0.00B | 0.11 |
| 2016-06-30 | $0.00B | $0.00B | 0.49 |
| 2016-03-31 | $0.00B | $0.00B | 0.11 |
| 2015-12-31 | $0.00B | $0.00B | 0.04 |
| 2015-09-30 | $0.00B | $0.00B | 0.05 |
| 2015-06-30 | $0.00B | $0.00B | 0.06 |
| 2015-03-31 | $0.00B | $0.00B | 0.10 |
| 2014-12-31 | $0.00B | $0.00B | 0.14 |
| 2014-09-30 | $0.00B | $0.00B | 0.05 |
| 2014-06-30 | $0.00B | 0.00 | |
| 2014-03-31 | $0.00B | 0.00 | |
| 2013-12-31 | $0.00B | 0.00 | |
| 2013-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.002B | $0.001B |
| Glucose Health, Inc. is involved in manufacturing dietary supplements for Type 2 diabetes. The company's principal product is Glucose Health natural blood sugar maintenance product. Glucose Health, Inc. is based in Bentonville, Arkansas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $206.313B | 26.32 |
| Stryker (SYK) | United States | $147.965B | 33.35 |
| Boston Scientific (BSX) | United States | $133.750B | 38.45 |
| EssilorLuxottica (ESLOY) | France | $111.202B | 0.00 |
| Medtronic (MDT) | Ireland | $110.623B | 16.43 |
| Haleon (HLN) | United Kingdom | $43.999B | 28.59 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.245B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.920B | 19.67 |
| ResMed (RMD) | United States | $36.601B | 30.08 |
| Terumo (TRUMY) | Japan | $30.306B | 42.80 |
| Koninklijke Philips (PHG) | Netherlands | $25.519B | 19.53 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.300B | 14.20 |
| Insulet (PODD) | United States | $18.723B | 74.56 |
| Baxter (BAX) | United States | $17.008B | 11.07 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.240B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.937B | 39.98 |
| Bio-Rad Laboratories (BIO) | United States | $9.476B | 32.21 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.276B | 14.58 |
| TG Therapeutics (TGTX) | United States | $5.448B | 0.00 |
| Haemonetics (HAE) | United States | $4.414B | 21.54 |
| Prestige Consumer Healthcare (PBH) | United States | $4.158B | 20.68 |
| Perrigo (PRGO) | Ireland | $3.935B | 11.58 |
| ICU Medical (ICUI) | United States | $3.911B | 37.24 |
| Envista Holdings (NVST) | United States | $3.843B | 28.63 |
| Agios Pharmaceuticals (AGIO) | United States | $3.345B | 0.00 |
| Neogen (NEOG) | United States | $3.064B | 35.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.867B | 18.39 |
| QuidelOrtho (QDEL) | United States | $2.766B | 17.80 |
| LeMaitre Vascular (LMAT) | United States | $2.379B | 57.81 |
| Warby Parker (WRBY) | United States | $2.328B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.010B | 35.19 |
| AtriCure (ATRC) | United States | $1.763B | 0.00 |
| InMode (INMD) | Israel | $1.637B | 9.84 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.495B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.344B | 9.61 |
| Curaleaf Holdings (CURLF) | Canada | $1.313B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.260B | 0.00 |
| CeriBell (CBLL) | United States | $1.033B | 0.00 |
| Owens & Minor (OMI) | United States | $1.026B | 8.02 |
| National Vision Holdings (EYE) | United States | $0.975B | 32.58 |
| Phibro Animal Health (PAHC) | United States | $0.955B | 16.85 |
| Evolus (EOLS) | United States | $0.874B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.866B | 0.00 |
| Omeros (OMER) | United States | $0.690B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.679B | 30.06 |
| Cresco Labs (CRLBF) | United States | $0.605B | 0.00 |
| Surmodics (SRDX) | United States | $0.566B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.529B | 0.00 |
| Quanterix (QTRX) | United States | $0.479B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.468B | 0.00 |
| ZimVie (ZIMV) | United States | $0.401B | 33.79 |
| Biote (BTMD) | United States | $0.363B | 7.95 |
| Cerus (CERS) | United States | $0.338B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.333B | 31.70 |
| Valneva SE (VALN) | France | $0.322B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.320B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.286B | 19.20 |
| Zynex (ZYXI) | United States | $0.266B | 55.67 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.244B | 0.00 |
| High Tide (HITI) | Canada | $0.230B | 95.33 |
| MacroGenics (MGNX) | United States | $0.228B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.221B | 15.26 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| Brainsway (BWAY) | Israel | $0.161B | 96.80 |
| Zevia PBC (ZVIA) | United States | $0.161B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 19.43 |
| Jin Medical (ZJYL) | China | $0.151B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.130B | 0.00 |
| Veru (VERU) | United States | $0.107B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.71 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.081B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.072B | 37.00 |
| Jushi Holdings (JUSHF) | United States | $0.068B | 0.00 |
| Exagen (XGN) | United States | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.064B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.057B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.025B | 0.00 |
| Flora Growth (FLGC) | United States | $0.021B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.57 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |